sorafenib has been researched along with mobic in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (mobic) | Trials (mobic) | Recent Studies (post-2010) (mobic) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,739 | 396 | 936 |
| Protein | Taxonomy | sorafenib (IC50) | mobic (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.5593 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.4364 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.1514 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dong, X; Li, J; Li, T; Liu, F; Wang, F; Wang, X; Wang, Y; Wei, H; Xiu, P; Xu, Z; Zhong, J | 1 |
1 review(s) available for sorafenib and mobic
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for sorafenib and mobic
| Article | Year |
|---|---|
Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Meloxicam; Mice; Niacinamide; Phenylurea Compounds; Sorafenib; Thiazines; Thiazoles; Xenograft Model Antitumor Assays | 2015 |